The protease inhibitor lopinavir, boosted with ritonavir, as treatment for COVID-19: A rapid review
<p><strong>Background:</strong><br /> The HIV protease inhibitor lopinavir, boosted with ritonavir, has been used off-label to treat COVID-19. We aimed to synthesise the clinical evidence for lopinavir/ritonavir as a treatment for COVID-19.</p><br /> <p><...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
International Medical Press
2021
|